首页>
外文期刊>British Journal of Haematology
>Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma
【24h】
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma
展开▼
机译:Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma